Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,579 | 3 | 66.8% |
| Food and Beverage | $786.15 | 12 | 33.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $1,472 | 7 | $0 (2019) |
| Intuitive Surgical, Inc. | $515.28 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $244.63 | 3 | $0 (2019) |
| TESARO, Inc. | $120.23 | 1 | $0 (2019) |
| Stryker Corporation | $13.18 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $515.28 | 3 | Intuitive Surgical, Inc. ($515.28) |
| 2021 | $13.18 | 1 | Stryker Corporation ($13.18) |
| 2019 | $1,793 | 10 | Merck Sharp & Dohme Corporation ($1,472) |
| 2018 | $44.08 | 1 | AstraZeneca Pharmaceuticals LP ($44.08) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/16/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: SURGERY | ||||||
| 07/05/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $455.62 | General |
| Category: SURGERY | ||||||
| 07/05/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: SURGERY | ||||||
| 07/27/2021 | Stryker Corporation | SPY-PHI SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: ENDOSCOPY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $49.53 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $44.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $929.45 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Travel and Lodging | In-kind items and services | $194.35 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Merck Sharp & Dohme Corporation | MK-7339 (Drug) | Food and Beverage | In-kind items and services | $115.25 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $104.68 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $83.07 | General |
| 09/12/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $120.23 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $117.48 | General |
| Category: Oncology | ||||||
| 10/16/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $44.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 513 | 641 | $379,657 | $93,595 |
| 2022 | 13 | 473 | 562 | $449,666 | $97,772 |
| 2021 | 9 | 239 | 263 | $214,576 | $50,251 |
| 2020 | 4 | 72 | 108 | $29,825 | $10,823 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 34 | $5,032 | $1,922 | 38.2% |
| 58100 | Biopsy of lining of uterus | Office | 2022 | 12 | 12 | $3,096 | $1,005 | 32.5% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 24 | 24 | $91,397 | $17,956 | 19.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $20,629 | $8,885 | 43.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $14,985 | $6,177 | 41.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 43 | $9,417 | $4,375 | 46.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 23 | $6,762 | $3,400 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 41 | $6,191 | $3,048 | 49.2% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2021 | 13 | 13 | $55,419 | $2,847 | 5.1% |
| 58558 | Biopsy and/or removal of polyp of the uterus using an endoscope | Facility | 2021 | 11 | 11 | $5,545 | $1,874 | 33.8% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 14 | 14 | $4,231 | $1,689 | 39.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 47 | $11,217 | $3,951 | 35.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 30 | $9,429 | $3,646 | 38.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 13 | 13 | $6,233 | $2,061 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 18 | $2,946 | $1,165 | 39.5% |
About Dr. Beverly Long, M.D
Dr. Beverly Long, M.D is a Gynecologic Oncology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2011. The National Provider Identifier (NPI) number assigned to this provider is 1932497245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beverly Long, M.D has received a total of $2,366 in payments from pharmaceutical and medical device companies, with $515.28 received in 2022. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Travel and Lodging" ($1,579).
As a Medicare-enrolled provider, Long has provided services to 1,297 Medicare beneficiaries, totaling 1,574 services with total Medicare billing of $252,441. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Sarasota, FL
- Active Since 07/20/2011
- Last Updated 10/16/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1932497245
Products in Payments
- MK-7339 (Drug) $1,368
- Da Vinci Surgical System (Device) $515.28
- ZEJULA (Drug) $120.23
- LYNPARZA (Drug) $117.48
- KEYTRUDA (Biological) $104.68
- SPY-PHI SYSTEM (Device) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.